BROKERS CHOICE: SANSERA, DEVYANIINTER, BIOCON, APOLLOHOSPI, VODAFONE, BIRLASOFT, SAIL, NEULAND

AHMEDABAD, 12 FEBRUARY: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

Nomura on Sansera: Maintain Buy on Company, raise target price at Rs 1668 (Positive)

Bernstein on Devyani Int: Maintain Buy on Company, raise target price at Rs 230 (Positive)

Nuvama on Devyani Int: Maintain Buy on Company, raise target price at Rs 214 (Positive)

HSBC on Biocon: Maintain Buy on Company, target price at Rs 430 (Positive)

UBS on Apollo Hospitals: Maintain Buy on Company, raise target price at Rs 8500 (Positive)

UBS on Vodafone Idea: Maintain Buy on Company, target price at Rs 13 (Positive)

CLSA on Cement: Expect cement demand to accelerate in Q4 & heading into FY26 after a weak last year. Ambuja, Ultratech and Dalmia Bharat top picks (Positive)

Nuvama on Apollo Hospitals: Maintain Buy on Company, cut target price at Rs 8200 (Neutral)

Citi on Apollo Hospitals: Maintain Buy on Company, cut target price at Rs 8260 (Neutral)

HSBC on Apollo Hospitals: Maintain Buy on Company, cut target price at Rs 8130 (Neutral)

Jefferies on Apollo Hospitals: Maintain Buy on Company, cut target price at Rs 7900 (Neutral)

Nomura on Birlasoft: Maintain Neutral on Company, target price at Rs 560 (Neutral)

Macquarie on Birlasoft: Maintain Buy on Company, target price at Rs 710 (Neutral)

CLSA on Vodafone Idea: Maintain Underperform on Company, target price at Rs 6 (Neutral)

Macquarie on Vodafone Idea: Maintain Neutral on Company, target price at Rs 7 (Neutral)

JP Morgan on SAIL: Maintain Neutral on Company, target price at Rs 112 (Neutral)

HSBC on Persistent: Maintain Hold on Company, target price at Rs 5650 (Neutral)

GS on Neuland Labs: Maintain Buy on Company, target price at Rs 15850 (Neutral)

Nuvama on Birlasoft: Maintain Reduce on Company, cut target price at Rs 465 (Negative)

Zoomed into item.

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)